Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.2M Buy
+108,617
New +$22.5M 0.13% 55
2026
Q1
Sell
-26,099
Closed -$6.29M 332
2025
Q4
$6.29M Buy
26,099
+10,237
+65% +$2.62M 0.12% 66
2025
Q3
$4.34M Buy
15,862
+11,175
+238% +$3.05M 0.12% 66
2025
Q2
$1.21M Buy
4,687
+3,145
+204% +$750K 0.05% 90
2025
Q1
$345K Buy
+1,542
New +$360K 0.01% 184

Other funds holding RMD

SIH Partners's RMD Position: Q2 2026 in Review

SIH Partners opened a new position in ResMed (RMD) in Q2 2026: 108,617 shares worth $21.2M. The stake represents 0.13% of the portfolio and ranks #55 among its holdings. This is a return to the name: SIH Partners previously reported a position in RMD as recently as Q4 2025.

SIH Partners first reported a position in RMD in Q1 2025 and has held it in 5 quarters since. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • SIH Partners held 108,617 shares of ResMed worth $21.2M as of Q2 2026.
  • ResMed was a new SIH Partners position in Q2 2026.
  • ResMed made up 0.13% of SIH Partners's portfolio in Q2 2026, its #55 holding.
  • SIH Partners first reported a position in ResMed in Q1 2025 and has held it in 5 quarters since.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on SIH Partners's 13F filing for Q2 2026, filed 14 Aug 2026.